https://www.selleckchem.com/pr....oducts/mitoquinone-m
After 1-year follow-up of the MHOC, a significant improvement in HRQoL was seen in adults (p less then 0.033) and in proxy ratings of parents (p less then 0.0001); TS remained high with no change by MHOC intervention. Patients reported good HRQoL and TS. Most of them were evaluated as having a good treatment adherence. After implementation of the MHOC, adult patients reported a better HRQoL. Such a mobile medical care service is considered beneficial for patients, especially with limited access to a HTC. Georg Thieme Ve